The Cancer Education Program aims to introduce twenty-five first and second year medical students to the field of oncology through participation in an eight-week research assistant ship in a comprehensive cancer center. These medical students are provided an opportunity to participate in the development and conduct of basic laboratory and clinical research projects. Laboratory research projects concentrate on one of the following areas: molecular biology, cell biology, cellular biochemistry and biophysics; immunology, molecular pharmacology and therapeutics, clinical research, and cancer control and prevention. Clinical research projects focus on one of the following areas: diagnosis and treatment of cancer, cancer epidemiology, cancer control and prevention, psychosocial studies, supportive care and quality of life issues, and cancer information outreach. This educational program provides many of these students with their first biomedical research experience under the direction of an established investigator in an environment dedicated to oncology research. The goal of the fellowship is to encourage future careers in oncology and research. Students who participate in this program gain knowledge and insights pertaining to oncology research theory and methodology early in their medical training. For many students, the fellowship is their first exposure to the field of oncology. Many students begin the cancer education program questioning the field of oncology and with some apprehension about treating the cancer patients. Although the research projects focus on various aspects of cancer and different approaches to managing the disease, past students' summaries highlight their greater understanding of the importance of preventive regimes, the value of early detection, and a knowledge that many of the manifestations of the disease can be controlled. Evaluations of the program indicate upon completion that student attitudes about cancer are more positive. Students cherish the fact that they are able to contribute to projects whose results may benefit future patients. Through their summer experiences, many have discovered the connection that exists between bench science and its direct clinical application.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA020449-27
Application #
6737517
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1977-07-01
Project End
2006-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
27
Fiscal Year
2004
Total Cost
$227,883
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Gollub, Marc J; Blazic, Ivana; Bates, David D B et al. (2018) Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings? Eur Radiol :
Lowery, Maeve A; Wong, Winston; Jordan, Emmet J et al. (2018) Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms. J Natl Cancer Inst 110:1067-1074
Lowery, Maeve A; Kelsen, David P; Capanu, Marinela et al. (2018) Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. Eur J Cancer 89:19-26
O'Reilly, Eileen M; Lee, Jonathan W; Lowery, Maeve A et al. (2018) Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma. Cancer 124:1374-1382
Williams, Ryan M; Shah, Janki; Tian, Helen S et al. (2018) Selective Nanoparticle Targeting of the Renal Tubules. Hypertension 71:87-94
Barzilai, Ori; McLaughlin, Lily; Amato, Mary-Kate et al. (2018) Predictors of quality of life improvement after surgery for metastatic tumors of the spine: prospective cohort study. Spine J 18:1109-1115
Zhang, Jingjing; Markova, Svetlana; Garcia, Alejandro et al. (2018) Evaluation of automatic contour propagation in T2-weighted 4DMRI for normal-tissue motion assessment using internal organ-at-risk volume (IRV). J Appl Clin Med Phys 19:598-608
Corines, Marina J; Nougaret, Stephanie; Weiser, Martin R et al. (2018) Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis Colon Rectum 61:193-201
Kunimoto, Hiroyoshi; Meydan, Cem; Nazir, Abbas et al. (2018) Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell 33:44-59.e8
Gollub, Marc J; Hotker, Andreas M; Woo, Kaitlin M et al. (2018) Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics. Abdom Radiol (NY) 43:1575-1582

Showing the most recent 10 out of 69 publications